Zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications

Zealthy announced an expansion of its insurance-coordination program to support eligible patients prescribed GLP-1 weight-loss medications like Wegovy, Zepbound, Ozempic, and Mounjaro. The enhanced program streamlines prior-authorization submissions, insurance verification, and coverage determinations while maintaining that insurance companies retain full authority over approval decisions and patient costs.